“…The expression of CXCL12 in human atherosclerotic plaques (Abi-Younes et al, 2000), the Abbreviations: 7-AAD, 7-aminoactinomycin D; BSA, bovine serum albumin; CIM, cell invasion/migration; CO, carbon monoxide; CS, cigarette smoke; CXCL12, C-X-C motif ligand 12; DNPH, dinitrophenylhydrazine; E-plate, electrical impedance plate; fMLP, N-formylmethionyl-leucyl-phenylalanine; GM-CSF, granulocyte-macrophage colony-stimulating factor; HCAECs, human coronary arterial endothelial cells; HGF, hepatocyte growth factor; ICAM1, intercellular adhesion molecule-1; IL-8, interleukin-8; LC-MS, liquid chromatography-electrospray ionization tandem mass spectrometry; MCP-1, monocyte chemoattractant protein-1; NO, nitrogen monoxide; pMRTP, prototypic modified risk tobacco product; RTCA-DP, real-time cell analyzer dualplate; SELE, E-selectin; TEM, transendothelial migration; THP-1, human monocytic cell line; TNF-α, tumor necrosis factor-α; VCAM1, vascular cell adhesion molecule. association between CXCL12 levels and coronary artery disease (Damas et al, 2002), and the potent chemotactic effects of CXCL12 on peripheral blood mononuclear cells (Liu et al, 2006) prompted us to investigate the effects of extracts from the reference cigarette 3R4F and a prototypic modified risk tobacco product (pMRTP) on CXCL12-dependent transendothelial migration (TEM) of THP-1 cells, a monocytic cell line that expresses CXCR4 (Tripathi et al, 2014).…”